GlassScriptPhysician profile
Mark Daniel Van Poppel
NPI 1407062235
$2,938.82
in general payments reported to CMS, 2019-2025
15 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $126 · 2021: $182 · 2022: $1,371 · 2023: $167 · 2024: $482 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,601.95 | 2020-2024 | Es2 Spinal System, Capri Corpectomy Cage System, N/A |
| Medtronic, INC. | $531.93 | 2022-2025 | Duet, Accurian, Unid_pass |
| Livanova USA, INC. | $194.57 | 2019-2022 | |
| Omniscient Neurotechnology America LTD | $150.00 | 2021 | |
| Kls-Martin L.P. | $128.42 | 2025 | |
| Longeviti Neuro Solutions INC | $57.31 | 2020 | |
| Depuy Synthes Sales INC. | $45.86 | 2019-2022 | |
| Brainlab, INC. | $39.41 | 2025 | Brainlab, INC. |
| Aesculap, INC. | $36.27 | 2021-2023 | M.Blue |
| Arbor Pharmaceuticals, INC. | $33.86 | 2019 | |
| Integra Lifesciences Corporation | $32.20 | 2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Monteris Medical Corporation | $27.40 | 2020 | |
| Globus Medical, INC. | $23.57 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.43 | 2022 | |
| Medtronic USA, INC. | $14.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Van Poppel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.